GlassScriptPhysician profile
Kaylee Miller
NPI 1215342068
$10,005.15
in general payments reported to CMS, 2019-2025
20 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $1,407 · 2021: $102 · 2022: $3,685 · 2023: $875 · 2024: $388 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,734 · Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,733.66 |
| Food and Beverage | $1,395.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,572.54 | 2019-2025 | |
| Gemini Medical LLC | $1,327.16 | 2019-2022 | |
| Foundation Medical, LLC | $617.26 | 2023-2025 | |
| Stryker Corporation | $380.78 | 2020-2025 | Augment Injectable, Allofiber, Allopure |
| Smith+Nephew, INC. | $306.30 | 2019-2025 | Grafix, Stravix Mesh, Oasis |
| Integra Lifesciences Corporation | $190.52 | 2019-2020 | |
| Trilliant Surgical LLC. | $122.36 | 2019 | |
| Sioux Surgical INC | $106.67 | 2023 | |
| Organogenesis INC. | $103.45 | 2019-2021 | |
| Depuy Synthes Sales INC. | $61.37 | 2019 | |
| Kerecis Limited | $56.30 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Hydrofera LLC | $44.15 | 2024-2025 | Hydrofera Blue, Hydrofera Blue Ready - Border |
| Ethicon US, LLC | $24.91 | 2022 | |
| Amgen INC. | $18.22 | 2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $16.48 | 2024 | Eliquis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.09 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $14.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.33 | 2021 | |
| Phathom Pharmaceuticals, INC. | $6.55 | 2025 | Voquezna |
| Orthofix Medical, INC. | $6.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylee Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.